Evidence map›Paper›PMID 20347815›Full record

ArticleGastroenterology2010

Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression.

Kei Sakamoto, Yohko Hikiba, Hayato Nakagawa, Yoku Hayakawa, Ayako Yanai, Masao Akanuma, Keiji Ogura, Yoshihiro Hirata, Klaus H Kaestner, Masao Omata and 1 more

Abstract read
In one paragraph

Article in Gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. The Role of Proinflammatory Biomarkers in Oral Cancer Pathophysiology.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Bioinformatic Analysis ofInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Kelch-like proteins in the gastrointestinal tumors.Acta pharmacologica Sinica · 2023
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. IKBKB rs2272736 is Associated with Gastric Cancer Survival.Pharmacogenomics and personalized medicine · 2020
    Article
  17. Article
  18. Review
  19. Expression of Allograft Inflammatory Factor-1 (AIF-1) in Hepatocellular Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Kei SakamotoDivision of Gastroenterology, Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.
Yohko Hikiba
Hayato Nakagawa
Yoku Hayakawa
Ayako Yanai
Masao Akanuma
Keiji Ogura
Yoshihiro Hirata
Klaus H Kaestner
Masao Omata
Shin Maeda
The University of Tokyo · JPInstitute for Adult Diseases Asahi Life Foundation · JPUniversity of Pennsylvania · US

Funding

REGULATORY CASCADES IN GASTROINTESTINAL PROLIFERATIONR01DK053839 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 1998 to 2011
$4.5M
NIDDK NIH HHS R01 DK053839
6 · The paper itself

Abstract

BACKGROUND &

aimsNuclear factor-kappaB (NF-kappaB) is an important transcription factor involved in various biological processes, including carcinogenesis. However, it is unknown whether NF-kappaB activation is involved in gastric carcinogenesis.

methodsTo explore the roles of inhibitor of kappaB kinase (IKKbeta), the key kinase for NF-kappaB activation, in gastric epithelium, we established a conditional gastric mucosal epithelium knockout mouse (Ikkbeta(DeltaST)). Gastric cancer was induced using N-methyl-N-nitrosourea (MNU). After 8 months, the number of tumors and their sizes were evaluated. Apoptosis was analyzed by terminal deoxynucleotidyl transferase-mediated deoxyuridine nick-end labeling staining, and levels of inflammatory cytokines were measured.

resultsNo phenotypical or histologic difference was observed between untreated Ikkbeta(DeltaST) and controls (Ikkbeta(F/F)). The number of tumors was significantly less in the MNU-treated Ikkbeta(DeltaST) group than in the Ikkbeta(F/F) group (mean +/- standard error, 2.21 +/- 0.48 vs 0.80 +/- 0.23), and the size of the tumors did not differ (2.75 +/- 0.99 vs 2.89 +/- 1.12 mm). After a single oral dose of MNU, interleukin (IL)-1alpha was up-regulated significantly in control mice compared with Ikkbeta(DeltaST) mice, whereas the levels of IL-1beta, IL-6, and tumor necrosis factor-alpha were unchanged. MNU significantly increased apoptotic cell death in Ikkbeta(DeltaST) mice compared with Ikkbeta(F/F) mice, and apoptosis was dependent on decreased IL-1alpha expression. IL-1alpha also induced the proliferation of gastric cancer cells. Fewer tumors were observed in IL-1-receptor knockout mice (Il-1r(-/-); 1.17 +/- 0.44) than in control mice (2.42 +/- 0.52).

conclusionsIKKbeta regulates gastric carcinogenesis via IL-1alpha expression, which is associated with anti-apoptotic signaling and cell proliferation.

Indexed as

AnimalsApoptosisCell Line, TumorCell ProliferationHumansI-kappa B KinaseInterleukin-1alphaMethylnitrosoureaMiceMice, Inbred C57BLMice, KnockoutNF-kappa BReceptors, Interleukin-1Stomach NeoplasmsI-kappa B KinaseInterleukin-1alphaMethylnitrosoureaNF-kappa BReceptors, Interleukin-1

Identifiers

PMID20347815
PMCPMC3156098
OpenAlexW2113409343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.